GlassScriptPhysician profile
Miral A Subhani
NPI 1588977409
$1,551.97
in general payments reported to CMS, 2019-2025
17 companies · $69.43 in 2025
The $69.43 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $155 · 2021: $169 · 2022: $466 · 2023: $199 · 2024: $294 · 2025: $69.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $359.15 | 2019-2023 | Senza |
| Relievant Medsystems, INC. | $244.32 | 2020-2022 | |
| Spinal Simplicity, LLC | $236.95 | 2024 | Ha Minuteman G3-R |
| Abbvie INC. | $185.01 | 2020-2022 | |
| Intuitive Surgical, INC. | $131.39 | 2023 | Da Vinci Surgical System |
| Medtronic USA, INC. | $81.81 | 2019 | |
| Medtronic, INC. | $62.44 | 2022 | |
| Gilead Sciences, INC. | $53.36 | 2019-2021 | |
| Braintree Laboratories, INC. | $35.01 | 2021-2024 | Sutab |
| Nalu Medical, INC. | $24.63 | 2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $23.81 | 2024 | Freestyle Libre 3 |
| Spr Therapeutics, INC | $23.20 | 2025 | Sprint Pns System |
| Curonix LLC | $21.60 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $20.78 | 2022 | |
| Janssen Pharmaceuticals, INC | $16.59 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $16.58 | 2022 | |
| Novo Nordisk INC | $15.34 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miral Subhani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.